Viewing Study NCT04888468

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2026-02-03 @ 6:47 AM
Study NCT ID: NCT04888468
Status: COMPLETED
Last Update Posted: 2022-03-18
First Post: 2021-05-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
Sponsor: Chongqing Precision Biotech Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None Relapsed Pediatric ALL View
None Refractory Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR-T View
None CD19 View
None B-ALL View